Clinical Trial Update: Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial) [Phase 3]

View source ↗

Summary

Phase 3 GALACTUS trial evaluating GLP-1 receptor agonists and SGLT2 inhibitors for patients with ST-segment elevation myocardial infarction is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• GLP-1 receptor agonist
• SGLT2 inhibitor

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Acute Myocardial Infarction With ST Elevation | Phase 3 | Status: RECRUITING